Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
New York Exchange Gives Lannett Six Months To Meet Standards
Lannett ‘Evaluating All Available Options To Regain Compliance’
Mar 29 2022
•
By
Dean Rudge
Lannett is looking to push its share price back above $1 • Source: Alamy
More from Regulation
More from Policy & Regulation